In addition, our results also showed that highexpression of KMO in HCC patients at TNM I stage was closely associated with therisk of recurrence and shorter survival time (OS, p = 0.0042; TTR,p = 0.0500). This evidence concerns the gene KMO and hepatocellular carcinoma.